RAMAT GAN, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...
For years, people with prediabetes have been told the same thing: lose weight or risk developing diabetes. But new research flips that idea on its head, showing that blood sugar can return to normal ...
PRMT5 inhibitors are under clinical investigation for pancreatic ductal adenocarcinoma (PDAC), but strategies to maximize their therapeutic efficacy remain undefined. Here, we sought to determine ...
It’s a question that has perplexed scientists for decades. Here’s what they have untangled so far. By Simar Bajaj For something so universal, graying remains oddly mysterious. Each strand of hair ...
Proper nutrition is important for maintaining a good quality of life, especially after being diagnosed with pancreatic cancer. Eating healthy foods can help a patient recover from surgery and minimize ...
Pancreatic cancer continues to be a devastating disease, with an overall 5-year survival rate of around 13%. Accounting for about 3% of all cancers, it is the third leading cause of cancer death in ...
What Is Loargys, and Why Does It Matter? Loargys is an enzyme-based medicine that has been granted accelerated approval by the FDA for managing high levels of the amino acid arginine (hyperargininemia ...
Qiang Li and colleagues have created “cyborg” pancreatic organoids that combine stretchy miniature electronics with stem cell-derived pancreatic islets, using the implanted electronics to monitor ...
Table: Global Exocrine Pancreatic Insufficiency Market (by Drug Type), $Million, 2024-2035 Table: Global Exocrine Pancreatic Insufficiency Market (by Region ...
Ramat Gan, Israel, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results